Incyte Corp (INCY)
59.14 x 1 68.00 x 1
Post-market by (Cboe BZX)
60.60 -0.08 (-0.13%) 03/28/25 [NASDAQ]
59.14 x 1 68.00 x 1
Post-market 60.60 unch (unch) 16:20 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | INCY | AZN | AMGN | GILD | VRTX |
| Company | Incyte Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 60.72 | 73.70 | 307.44 | 111.15 | 504.79 |
| High | 60.97 | 74.19 | 308.17 | 112.38 | 504.79 |
| Low | 60.35 | 73.43 | 304.71 | 109.64 | 491.37 |
| Last | 60.60 | 73.79 | 306.95 | 111.79 | 492.69 |
| Change | -0.08 | +0.95 | +1.18 | +0.63 | -9.86 |
| % Change | -0.13% | +1.30% | +0.39% | +0.57% | -1.96% |
| Volume | 1,198,500 | 3,427,600 | 1,768,500 | 7,845,100 | 1,281,000 |
| 20-Day Average Volume | 2,155,415 | 5,295,415 | 3,044,535 | 10,720,840 | 1,339,665 |
| Previous Close | 60.68 | 72.84 | 305.77 | 111.16 | 502.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 65.27 | 75.74 | 314.48 | 111.99 | 499.74 |
| 20-Day Raw Stochastic | 14.28% | 30.15% | 10.63% | 46.46% | 35.66% |
| 20-Day Relative Strength | 33.28% | 49.00% | 51.20% | 58.46% | 52.96% |
| Weighted Alpha | -0.14 | +6.21 | +10.59 | +67.32 | +19.33 |
| Today's Opinion | 56% Sell | 24% Buy | 32% Buy | 80% Buy | 64% Buy |
| Previous Opinion | 56% Sell | 8% Sell | 16% Buy | 80% Buy | 88% Buy |
| Last Month's Opinion | 88% Buy | 24% Buy | 8% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.13% since 03/21/25 | -1.52% since 03/21/25 | -2.88% since 03/21/25 | +4.40% since 03/21/25 | -2.09% since 03/21/25 |
| Low | 60.24 on 03/27/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 106.10 on 03/24/25 | 491.37 on 03/28/25 |
| High | 63.31 on 03/24/25 | 75.12 on 03/25/25 | 317.58 on 03/24/25 | 112.38 on 03/28/25 | 513.97 on 03/24/25 |
| 1-Month | |||||
| %Chg | -17.55% since 02/28/25 | -3.18% since 02/28/25 | -0.36% since 02/28/25 | -2.20% since 02/28/25 | +2.69% since 02/28/25 |
| Low | 58.46 on 03/18/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 104.70 on 03/20/25 | 477.73 on 03/03/25 |
| High | 73.45 on 03/03/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 3-Month | |||||
| %Chg | -12.47% since 12/27/24 | +11.36% since 12/27/24 | +16.87% since 12/27/24 | +18.79% since 12/27/24 | +20.53% since 12/27/24 |
| Low | 58.46 on 03/18/25 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 397.24 on 01/13/25 |
| High | 76.96 on 02/07/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -7.94% since 09/27/24 | -4.93% since 09/27/24 | -4.87% since 09/27/24 | +33.70% since 09/27/24 | +6.44% since 09/27/24 |
| Low | 58.46 on 03/18/25 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
| High | 83.95 on 11/08/24 | 79.76 on 10/02/24 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,743,036 | 225,892,416 | 164,261,168 | 138,432,656 | 129,049,824 |
| Shares Outstanding, K | 193,524 | 3,101,214 | 537,205 | 1,245,346 | 256,790 |
| Annual Sales | 4,241,220,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 32,610,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,178,700,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | 201,210,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.76 | 0.41 | 0.53 | 0.21 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.43 on 02/10/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 04/29/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 360.35 | 17.69 | 15.42 | 23.70 | 0.00 |